ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
M

Loss of Function of the SETD2 Tumor Suppressor is a Recurrent Event in Advanced-phase Chronic Myeloid Leukemia, is Due to Post-translational Mechanisms and Fosters Genetic Instability

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Manuela Mancini
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Manuela Mancini
5 views
January 2, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Scientific Session 3: The Microenvironment and Mechanisms of Transformation
11:41
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Loss of Function of the SETD2 Tumor Suppressor is a Recurrent Event …

Feat. M. Mancini
17:28
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

CML Hematopoietic Stem Cells Expressing IL-1RAP May be Targets of Ch…

Feat. C. Ferrand